Separately, Zacks Investment Research cut Gevo from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd.
Shares of NASDAQ:GEVO traded up $0.01 during trading on Thursday, hitting $2.36. The company’s stock had a trading volume of 121,152 shares, compared to its average volume of 232,144. Gevo has a fifty-two week low of $1.79 and a fifty-two week high of $4.97. The firm’s 50-day simple moving average is $2.25. The stock has a market capitalization of $29.12 million, a P/E ratio of -0.45 and a beta of 2.69.
In other news, insider Timothy J. Cesarek acquired 25,000 shares of the business’s stock in a transaction on Thursday, June 6th. The shares were purchased at an average price of $1.91 per share, for a total transaction of $47,750.00. Following the completion of the purchase, the insider now directly owns 30,000 shares of the company’s stock, valued at approximately $57,300. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 3.41% of the company’s stock.
An institutional investor recently bought a new position in Gevo stock. Wedbush Securities Inc. bought a new stake in shares of Gevo Inc (NASDAQ:GEVO) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 30,500 shares of the energy company’s stock, valued at approximately $67,000. Wedbush Securities Inc. owned about 0.26% of Gevo at the end of the most recent quarter. 8.55% of the stock is currently owned by institutional investors and hedge funds.
Gevo Company Profile
Gevo, Inc is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo; Gevo Development and Agri-Energy. The Gevo segment focuses in the research and development activities related to the future production of isobutanol, including the development of the firm’s proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company’s isobutanol technology.
Featured Article: What is a good rate of return for a mutual fund?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.